The effects of lofepramine and desmethylimipramine on tryptophan metabolism and disposition in the rat.
Acute and chronic administration of lofepramine and its major metabolite desmethylimipramine (DMI) to rats elevates brain tryptophan concentration, thereby enhancing cerebral 5-hydroxytryptamine (5-HT) synthesis, by increasing the availability of circulating tryptophan to the brain, secondarily to inhibition of liver tryptophan pyrrolase (tryptophan 2,3-dioxygenase, L-tryptophan:O2 oxidoreductase, decyclizing; EC 1.13.11.11) activity. The pyrrolase inhibition by lofepramine occurs independently of metabolism to DMI, because it can be demonstrated directly in vitro. Lofepramine also differs from DMI in its action profile on the above and related aspects of tryptophan metabolism and disposition. These results demonstrate that lofepramine influences tryptophan and 5-HT metabolism and disposition independently of its major metabolite DMI, and are discussed briefly in relation to the mechanism of action of antidepressants.
Badawy
A A
AA
South Glamorgan Health Authority, Biomedical Research Laboratory, Whitchurch Hospital, Cardiff, U.K.
Morgan
C J
CJ
Dacey
A
A
Stoppard
T
T
D000818:Animals; D003891:Desipramine / Q000494:pharmacology*; D004334:Drug Administration Schedule; D006427:Hemin / Q000494:pharmacology; D006854:Hydrocortisone / Q000494:pharmacology; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008127:Lofepramine / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D014364:Tryptophan / Q000378:metabolism* / Q000493:pharmacokinetics; D014366:Tryptophan Oxygenase / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism
D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D006427:Hemin; D014364:Tryptophan; D014366:Tryptophan Oxygenase; D008127:Lofepramine; D003891:Desipramine; D006854:Hydrocortisone